Optimer Pharmaceuticals (OPTR) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Income (loss) from operations: -27.12M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income (loss) from operations: -27.12M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q3 EPS of ($0.56), $0.08 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $17.89 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Optimer Pharmaceuticals (OPTR) click here.
For earnings history and earnings-related data on Optimer Pharmaceuticals (OPTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
